For each 1-standard deviation (SD) increase in ADA (OR = 1.16, 95%CI: 1.00-1.33; P = 0.041) and CD40L receptor (OR = 1.20, 95%CI: 1.02–1.40; P = 0.025) levels, the risk of MG increased by 16% and 20%, respectively. Here, ADA is linked to myasthenia gravis.